STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 106 filers reported holding STOKE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $45,238,000 | +73.3% | 1,343,956 | +100.0% | 0.29% | -10.9% |
Q1 2021 | $26,100,000 | -37.3% | 671,978 | 0.0% | 0.33% | -26.2% |
Q4 2020 | $41,616,000 | +84.9% | 671,978 | 0.0% | 0.45% | +35.9% |
Q3 2020 | $22,505,000 | +40.5% | 671,978 | 0.0% | 0.33% | +27.0% |
Q2 2020 | $16,013,000 | +4.1% | 671,978 | 0.0% | 0.26% | -35.4% |
Q1 2020 | $15,388,000 | -19.1% | 671,978 | 0.0% | 0.40% | +6.1% |
Q4 2019 | $19,030,000 | +31.8% | 671,978 | 0.0% | 0.38% | -2.8% |
Q3 2019 | $14,440,000 | -26.3% | 671,978 | 0.0% | 0.39% | -13.6% |
Q2 2019 | $19,601,000 | – | 671,978 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skorpios Trust | 14,443,681 | $56,908,103 | 99.78% |
Lynx1 Capital Management LP | 1,710,154 | $6,738,007 | 4.46% |
COWEN AND COMPANY, LLC | 3,721,659 | $14,663,336 | 1.03% |
Redmile Group, LLC | 3,872,696 | $15,258,422 | 0.73% |
RTW INVESTMENTS, LP | 4,390,558 | $17,298,799 | 0.36% |
Birchview Capital, LP | 85,000 | $334,900 | 0.28% |
Cormorant Asset Management, LP | 1,087,807 | $4,285,960 | 0.25% |
Granahan Investment Management | 851,201 | $3,353,732 | 0.12% |
GSA CAPITAL PARTNERS LLP | 348,069 | $1,371 | 0.12% |
Simplify Asset Management Inc. | 102,985 | $405,761 | 0.05% |